Evidence map›Paper›PMID 29922468›Full record

ArticleNew microbes and new infections2018

First report of

M Almuzara, R Cittadini, M L Estraviz, A Ellis, C Vay

Open access · goldAbstract readCase Reports
In one paragraph

Article in New microbes and new infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. First Report of a Carbapenem-ResistantInfection and drug resistance · 2026
    Article
  2. Article
  3. Article
  4. A new class A beta-lactamase gene blaScientific reports · 2023
    Article
  5. Review
  6. Bacteremia caused byFrontiers in medicine · 2023
    Article
  7. Article
  8. The Emergence of the GenusPathogens (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Case reports in infectious diseases · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

M AlmuzaraUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Laboratorio de Bacteriología, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Argentina.
R CittadiniSanatorio Mater Dei, Ciudad Autónoma de Buenos Aires, Argentina.
M L EstravizSanatorio Mater Dei, Ciudad Autónoma de Buenos Aires, Argentina.
A EllisSanatorio Mater Dei, Ciudad Autónoma de Buenos Aires, Argentina.
C VayUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Laboratorio de Bacteriología, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Argentina.
Sanatorio Otamendi y Miroli · ARUniversidad de Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association of

Indexed as

Comamonas kerstersiiemerging pathogenpsoas abscesssecondary peritonitisurinary tract infection

Identifiers

PMID29922468
PMCPMC6004729
OpenAlexW2789392286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.